Levin Capital Strategies L.P. Makes New $748,000 Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Levin Capital Strategies L.P. purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 8,377 shares of the exchange traded fund’s stock, valued at approximately $748,000.

A number of other large investors also recently bought and sold shares of XBI. EPG Wealth Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 152.7% in the 3rd quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock valued at $34,000 after acquiring an additional 278 shares during the period. Tennessee Valley Asset Management Partners purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $44,000. Wetzel Investment Advisors Inc. purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $45,000. Life Planning Partners Inc purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $64,000. Finally, Albion Financial Group UT purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $69,000.

SPDR S&P Biotech ETF Stock Up 1.4 %

Shares of XBI stock traded up $1.24 during mid-day trading on Thursday, reaching $88.57. The company’s stock had a trading volume of 7,996,242 shares, compared to its average volume of 11,675,642. The company’s 50 day simple moving average is $92.28 and its 200-day simple moving average is $85.06. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The firm has a market capitalization of $6.75 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.